Satyajit Kosuri

Satyajit Kosuri practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Satyajit Kosuri's NPI, 1306028451, was assigned on November 30, 2007. Satyajit Kosuri holds Illinois license 036141656.

Satyajit Kosuri's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Satyajit Kosuri's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Satyajit Kosuri is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Satyajit Kosuri to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Satyajit Kosuri practices. Vendor and product names are available with a free account.

Hematology and oncology is Satyajit Kosuri's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Satyajit Kosuri is licensed in Illinois.

CMS data shows 445 Medicare services from Satyajit Kosuri across 4 procedure codes in 2024, for 87 Medicare patients. Medicare paid $43,314 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 87 Medicare patients who saw Satyajit Kosuri in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 57% have high cholesterol. 15% are also on Medicaid. Their average risk score is 3.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Satyajit Kosuri's median patient age at 70, with 45% women.

In 2024, Satyajit Kosuri wrote 112 Medicare Part D claims for 19 patients. 30% of them were for generic drugs. CMS names the drug for 40 of them, across 2 drugs with 11 or more claims each, at $692,948 in total drug cost. In 2023, CMS named 33 claims across 2 drugs.

Satyajit Kosuri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Satyajit Kosuri as offering telehealth.

Dmand AI links 36 papers to Satyajit Kosuri, published from 2012 to 2025. 2020 was the busiest year, with 7. The most frequent topics are Hematopoietic Stem Cell Transplantation, Antineoplastic Combined Chemotherapy Protocols and Hematologic Neoplasms. Satyajit Kosuri has published most often in Blood Adv. Satyajit Kosuri's most frequent co-authors are Richard A. Larson, Andrew S. Artz, MD, MS and Peter A. Riedell.

Dmand AI links Satyajit Kosuri to 5 clinical trials, 2 of them phase 1 studies. Conditions studied include Bronchiolitis Obliterans Syndrome, Carcinoma, Merkel Cell and Leukemia, Myeloid, Acute.

CMS Open Payments shows 12 general payments to Satyajit Kosuri from 3 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 85% of the total. Sanofi and Genzyme US Companies paid the most, $7,692.